Literature DB >> 10627566

The S segment of rift valley fever phlebovirus (Bunyaviridae) carries determinants for attenuation and virulence in mice.

P Vialat1, A Billecocq, A Kohl, M Bouloy.   

Abstract

Unlike all the other Rift Valley fever virus strains (Bunyaviridae, Phlebovirus) studied so far, clone 13, a naturally attenuated virus, does not form the filaments composed of the NSs nonstructural protein in the nuclei of infected cells (R. Muller, J. F. Saluzzo, N. Lopez, T. Drier, M. Turell, J. Smith, and M. Bouloy, Am. J. Trop. Med. Hyg. 53:405-411, 1995). This defect is correlated with a large in-frame deletion in the NSs coding region of the S segment of the tripartite genome. Here, we show that the truncated NSs protein of clone 13 is expressed and remains in the cytoplasm, where it is degraded rapidly by the proteasome. Through the analysis of reassortants between clone 13 and a virulent strain, we localized the marker(s) of attenuation in the S segment of this attenuated virus. This result raises questions regarding the role of NSs in pathogenesis and highlights, for the first time in the Bunyaviridae family, a major role of the S segment in virulence and attenuation, possibly associated with a defect in the nonstructural protein.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10627566      PMCID: PMC111490          DOI: 10.1128/jvi.74.3.1538-1543.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  Non-random reassortment between the tripartite RNA genomes of La Crosse and snowshoe hare viruses.

Authors:  V Urquidi; D H Bishop
Journal:  J Gen Virol       Date:  1992-09       Impact factor: 3.891

2.  Neuroattenuation of an avirulent bunyavirus variant maps to the L RNA segment.

Authors:  M J Endres; C Griot; F Gonzalez-Scarano; N Nathanson
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

3.  The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis.

Authors:  A Kato; K Kiyotani; Y Sakai; T Yoshida; Y Nagai
Journal:  EMBO J       Date:  1997-02-03       Impact factor: 11.598

4.  Mapping of the mutations present in the genome of the Rift Valley fever virus attenuated MP12 strain and their putative role in attenuation.

Authors:  P Vialat; R Muller; T H Vu; C Prehaud; M Bouloy
Journal:  Virus Res       Date:  1997-11       Impact factor: 3.303

5.  Evaluation of the susceptibility of the 3C proteases of hepatitis A virus and poliovirus to degradation by the ubiquitin-mediated proteolytic system.

Authors:  R L Gladding; A L Haas; D L Gronros; T G Lawson
Journal:  Biochem Biophys Res Commun       Date:  1997-09-08       Impact factor: 3.575

6.  Use of reassortant viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccine.

Authors:  J F Saluzzo; J F Smith
Journal:  Vaccine       Date:  1990-08       Impact factor: 3.641

7.  Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment.

Authors:  R Muller; J F Saluzzo; N Lopez; T Dreier; M Turell; J Smith; M Bouloy
Journal:  Am J Trop Med Hyg       Date:  1995-10       Impact factor: 2.345

8.  Polygenic control of neuroinvasiveness in California serogroup bunyaviruses.

Authors:  C Griot; A Pekosz; D Lukac; S S Scherer; K Stillmock; D Schmeidler; M J Endres; F Gonzalez-Scarano; N Nathanson
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

9.  Persistent infection of mammalian cells by Rift Valley fever virus.

Authors:  A Billecocq; P Vialat; M Bouloy
Journal:  J Gen Virol       Date:  1996-12       Impact factor: 3.891

10.  Normal replication of vesicular stomatitis virus without C proteins.

Authors:  E Kretzschmar; R Peluso; M J Schnell; M A Whitt; J K Rose
Journal:  Virology       Date:  1996-02-15       Impact factor: 3.616

View more
  59 in total

1.  Reverse genetics system for Uukuniemi virus (Bunyaviridae): RNA polymerase I-catalyzed expression of chimeric viral RNAs.

Authors:  R Flick; R F Pettersson
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

2.  The nonstructural protein NSs induces a variable antibody response in domestic ruminants naturally infected with Rift Valley fever virus.

Authors:  José-Carlos Fernandez; Agnès Billecocq; Jean Paul Durand; Catherine Cêtre-Sossah; Eric Cardinale; Philippe Marianneau; Michel Pépin; Noël Tordo; Michèle Bouloy
Journal:  Clin Vaccine Immunol       Date:  2011-11-09

3.  Induction of DNA damage signaling upon Rift Valley fever virus infection results in cell cycle arrest and increased viral replication.

Authors:  Alan Baer; Dana Austin; Aarthi Narayanan; Taissia Popova; Markus Kainulainen; Charles Bailey; Fatah Kashanchi; Friedemann Weber; Kylene Kehn-Hall
Journal:  J Biol Chem       Date:  2012-01-05       Impact factor: 5.157

4.  Rift Valley fever virus structural and nonstructural proteins: recombinant protein expression and immunoreactivity against antisera from sheep.

Authors:  Bonto Faburay; William Wilson; D Scott McVey; Barbara S Drolet; Hana Weingartl; Daniel Madden; Alan Young; Wenjun Ma; Juergen A Richt
Journal:  Vector Borne Zoonotic Dis       Date:  2013-08-20       Impact factor: 2.133

Review 5.  The use of mice lacking type I or both type I and type II interferon responses in research on hemorrhagic fever viruses. Part 2: Vaccine efficacy studies.

Authors:  Marko Zivcec; Christina F Spiropoulou; Jessica R Spengler
Journal:  Antiviral Res       Date:  2020-01-22       Impact factor: 5.970

6.  Interplay between the Virus and Host in Rift Valley Fever Pathogenesis.

Authors:  Kaori Terasaki; Shinji Makino
Journal:  J Innate Immun       Date:  2015-02-27       Impact factor: 7.349

7.  Characterization of the Sandfly fever Naples species complex and description of a new Karimabad species complex (genus Phlebovirus, family Bunyaviridae).

Authors:  Gustavo Palacios; Robert B Tesh; Nazir Savji; Amelia P A Travassos da Rosa; Hilda Guzman; Ana Valeria Bussetti; Aaloki Desai; Jason Ladner; Maripaz Sanchez-Seco; W Ian Lipkin
Journal:  J Gen Virol       Date:  2013-10-04       Impact factor: 3.891

8.  NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription.

Authors:  Agnès Billecocq; Martin Spiegel; Pierre Vialat; Alain Kohl; Friedemann Weber; Michèle Bouloy; Otto Haller
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

9.  Rift Valley fever virus clearance and protection from neurologic disease are dependent on CD4+ T cell and virus-specific antibody responses.

Authors:  Kimberly A Dodd; Anita K McElroy; Megan E B Jones; Stuart T Nichol; Christina F Spiropoulou
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

Review 10.  Rift valley fever vaccines.

Authors:  Tetsuro Ikegami; Shinji Makino
Journal:  Vaccine       Date:  2009-11-05       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.